Tufts CSDD Study on Staff Diversity in Global Investigative Sites

The Tufts Center for the Study of Drug Development has published a summary of their two global surveys conducted in 2021 on clinical research staff diversity at investigative sites. The aim of the study was:

• To gather baseline measures of clinical research staff diversity at investigative sites, globally; analyze the
  operational capabilities of a wide variety of investigative sites; and gather healthcare professionals’ perceptions
  of clinical research.
• To inform sponsors and other stakeholders in the drug development process how to support greater staff
  diversity and increased patient diversity within investigative sites.

A summary of the findings can be found here